Skip to content

Nuvalent, Inc. NUVL Operating Income

Operating Income at other companies

Exelixis logo
ExelixisEXEL
$251.34M+34.5%
Revolution Medicines, Inc. logo
Revolution Medicines, Inc.RVMD
-$445.22M-84.9%
Incyte logo
IncyteINCY
$301.12M+46.8%
Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
$336.6M+702%
Natera, Inc. logo
Natera, Inc.NTRA
-$93.52M-18.1%
ALN
Alnylam PharmaceuticalsALNY

Other financials

Income statement

See full
Net income-$109.3M-29.2%
EPS (diluted)-$1.39-17.8%

Balance sheet

See full
Cash & equivalents$159.7M+32.2%
Total equity$1.2B+16.2%
Total assets$1.3B+20.4%

Cash flow

See full
Operating cash flow-$92.4M-68.5%

Valuation

See full
Market cap$9.77B+58.6%

Returns & leverage

See full
Return on equity-41.2%+7.5pp
Current ratio16.1×+1.7×

Where this comes from

Reported directly by Nuvalent, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The official record: Nuvalent, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nuvalent, Inc.'s operating income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Nuvalent, Inc.'s operating income?
Nuvalent, Inc. (NUVL) reported operating income of -$119.41M in Q1 2026.
How has Nuvalent, Inc.'s operating income changed year-over-year?
Nuvalent, Inc.'s operating income decreased by 25.9% year-over-year, from -$94.81M to -$119.41M.
What is the long-term trend for Nuvalent, Inc.'s operating income?
Over 4 years (2021 to 2025), Nuvalent, Inc.'s operating income has grown at a 73.4% compound annual growth rate (CAGR), from -$45.82M to -$414.31M.
What does operating income mean?
Profit earned from core business activities before interest and taxes.
How do you interpret operating income?
Higher values indicate strong operational profitability, while negative values indicate an operating loss common in early-stage clinical companies.
How does operating income compare across companies?
A standard measure of operational health across all public companies.